These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20161482)

  • 21. Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agent.
    Maclean DS; Khokhar AR; Tyle P; Perez-Soler R
    J Microencapsul; 2000; 17(3):307-22. PubMed ID: 10819419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acidity Functions. Values of the Quantity
    Bates RG; Gary R
    J Res Natl Bur Stand A Phys Chem; 1961; 65A(6):495-505. PubMed ID: 32196206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enthalpy and heat capacity changes for the proton dissociation of various buffer components in 0.1 M potassium chloride.
    Fukada H; Takahashi K
    Proteins; 1998 Nov; 33(2):159-66. PubMed ID: 9779785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions.
    Zhou M; Notari RE
    J Pharm Sci; 1995 May; 84(5):534-8. PubMed ID: 7658340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrolysis kinetics of the prodrug myristyl nicotinate.
    Altaani B; Haddad R; Al-Tarakji A; Alrabadi N
    Pharm Dev Technol; 2022 Dec; 27(10):1083-1092. PubMed ID: 36440492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution stability of ciclosidomine.
    Carney CF
    J Pharm Sci; 1987 May; 76(5):393-7. PubMed ID: 3656101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buffer capacity of biologics--from buffer salts to buffering by antibodies.
    Karow AR; Bahrenburg S; Garidel P
    Biotechnol Prog; 2013; 29(2):480-92. PubMed ID: 23296746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.
    Ahmed I; Day P
    Am J Hosp Pharm; 1987 Oct; 44(10):2287-90. PubMed ID: 3687969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation kinetics of phentolamine hydrochloride in solution.
    Wang DP; Tu YH; Allen LV
    J Pharm Sci; 1988 Nov; 77(11):972-6. PubMed ID: 3225760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ionised concentrations in calcium and magnesium buffers: Standards and precise measurement are mandatory.
    McGuigan JA; Kay JW; Elder HY
    Prog Biophys Mol Biol; 2016 Sep; 121(3):195-211. PubMed ID: 26975789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of buffer properties on cyclodextrin glucanotransferase reactions and cyclodextrin production from raw sago (Cycas revoluta) starch.
    Kamaruddin K; Illias RM; Aziz SA; Said M; Hassan O
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):117-25. PubMed ID: 15202937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buffers for the physiological pH range: acidic dissociation constants of zwitterionic compounds in various hydroorganic media.
    Taha M
    Ann Chim; 2005; 95(1-2):105-9. PubMed ID: 15801182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
    Taylor R; Sunderland B; Luna G; Czarniak P
    Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The equilibrium constant of the phosphoglyceromutase reaction.
    Clarke JB; Birch M; Britton HG
    Biochem J; 1974 Jun; 139(3):491-7. PubMed ID: 4854821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298.
    Zheng JY; Janis LJ
    Int J Pharm; 2006 Feb; 308(1-2):46-51. PubMed ID: 16316730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buffer solutions in drug formulation and processing: How pK
    Samuelsen L; Holm R; Lathuile A; Schönbeck C
    Int J Pharm; 2019 Apr; 560():357-364. PubMed ID: 30797864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of ionic strength and background electrolyte on pH measurements in metal ion adsorption experiments.
    Wiesner AD; Katz LE; Chen CC
    J Colloid Interface Sci; 2006 Sep; 301(1):329-32. PubMed ID: 16765363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions.
    Sundaramurthi P; Suryanarayanan R
    Pharm Res; 2011 Feb; 28(2):374-85. PubMed ID: 20927571
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.